The Food and Drug Administration (FDA) told the maker of Purell to discontinue marketing campaigns that includes claims for avoiding flu and ebola, according to an article on The New York Times website.
The campaigns also claim the product can prevent spread of MRSA and norovirus.
The FDA told Gojo Industries that its claims that Purell could reduce the potential for infection or prevent illnesses violated the Federal Food, Drug and Cosmetic Act.
The agency said it was reclassifying Purell as an unapproved drug, rather than an over-the-counter product.
Laser Scanning: Reducing Risk in Construction Projects
MOBs Get Smarter and More Complex as Space Pressures Mount
Ascension Saint Thomas Sets Date for Groundbreaking on New Hospital and Health Campus
Women in Construction Sees Growth on Florida Jobsite
Managing Soft Surfaces, Clean or Soiled